Clinical Trial Update: Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on using gene therapy with ganciclovir to treat stage IV melanoma. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)
• Gene therapy (vector unspecified)

Snippet

Sponsor: National Human Genome Research Institute (NHGRI) | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED